Increased hypodense eosinophils after activation with PAF-acether and calcium ionophore in asthmatic subjects

被引:5
作者
Agrawal, DK
Sarmiento, EU
Nabe, M
Miyagawa, H
Townley, RG
机构
[1] Allergic Disease Center, Creighton University, School of Medicine, Omaha
[2] Dept. Med., Med. Microbiol., I., Creighton University, School of Medicine, Omaha, NE 68178
关键词
bronchial asthma; eosinophils; platelet-activating factor; calcium ionophore; allergic inflammation;
D O I
10.3109/02770909609055362
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Eosinophils play a major role in the pathogenesis of bronchial asthma. In this study, we examined the density characteristics of blood eosinophils from 9 normal healthy individuals and 9 allergic asthmatic patients. Furthermore, the effect of platelet-activating factor, a potent mediator of inflammation, and calcium ionophore, A23187, on the density of normodense eosinophils (density >1.085 g/ml) has also been examined. Initially, asthmatic patients had 27.0 +/- 1.1% eosinophils of lighter density (density less than or equal to 1.081 g/ml), significantly greater than that in the normal individuals (7.5 +/- 0.5%). After exposure to platelet-activating factor (1 mu M) or calcium ionophore (A23187, 1 mu g/ml), the normodense eosinophils switched to hypodense in both groups: 16.7 +/- 2.1% and 54.2 +/- 3.7%, respectively, in normal individuals, and 30.6 +/- 5.7% and 77.4 +/- 2.3%, respectively, in asthmatic patients. These data demonstrated that a certain percentage of normodense eosinophils from asthmatics and normal subjects switched to hypodense after activation with platelet-activating factor or calcium ionophore. Furthermore, eosinophils from asthmatics switched to a greater degree than in normal subjects, suggesting that the normodense eosinophils in asthmatics become primed probably by endogenously released mediators.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 24 条
  • [1] Agrawal Devendra K., 1993, P171
  • [2] AGRAWAL DK, 1991, INFLAMMATORY CELLS M, P171
  • [3] COMPARISON OF HUMAN EOSINOPHILS FROM NORMALS AND PATIENTS WITH EOSINOPHILIA
    BASS, DA
    GROVER, WH
    LEWIS, JC
    SZEJDA, P
    DECHATELET, LR
    MCCALL, CE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (06) : 1265 - 1273
  • [4] CUSS FM, 1986, LANCET, V2, P189
  • [5] DAHL R, 1982, EUR J RESPIR DIS, V63, P23
  • [6] DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373
  • [7] DESIMONE C, 1982, CLIN EXP IMMUNOL, V48, P249
  • [8] THE APPEARANCE OF HYPODENSE EOSINOPHILS (HE) IN LATE PHASE ASTHMA
    FRICK, WE
    SEDGWICK, JB
    BUSSE, WW
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (01) : 208 - 208
  • [9] FUKUDA T, 1985, AM REV RESPIR DIS, V132, P981
  • [10] HETEROGENEITY OF HUMAN EOSINOPHILS
    FUKUDA, T
    GLEICH, GJ
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (02) : 369 - 373